We?ve taken notable enforcement actions to confront bad actors that put Americans at risk. We
cracked down on bogus stem cell therapies, on sham homeopathy, on unsafe medical device
products, on tobacco sales to minors, on unsafe dietary supplements, and on kratom.

The agency helped support major legislative efforts to secure a more modern framework for the
efficient regulation of diagnostic tests and over?the-counter drugs; to advance animal health
through a new pathway that makes the development of drugs targeting unmet animal health
needs more efficient; to support our efforts to address the opioid crisis with historic new
authorities and resources; to more efficiently advance safe and effective medical priorities for
our troops; and to sharply expand our interdiction work inside the international Mail Facilities.

We were strong in moments of crisis.

We dedicated ourselves to the recovery of Puerto Rico and mitigated and averted drug and
device shortages in its aftermath. We led a global investigation into impurities found in a class of
critical medicines. We restored critical functions and protected the public during a historic
government shutdown. We were transparent with the public in these and all our endeavors.

All of these efforts were broad undertakings. They took the collective dedication of the
professional staff of the FDA, whose commitment to the public health drove these and many
other objectives on behalf of Americans. All of these efforts will have palpable impacts on the
health of patients and the safety of families. We did all this, and much more, through the hard
work, scientific prowess, and public spiritedness of one of the most talented workforces in the
Federal government. l?m grateful to have shared these opportunities with my FDA colleagues.
I?m thankful for their support and commitment to our shared mission. And I?m thankful to my
family for their support in enabling me to take on the privilege of serving in this role.

I?m confident that the FDA will continue to advance all these efforts, and many other goals.

Sincerely,

was

Scott Gottlieb, MD
Commissioner of Food and Drugs